Related Experiment Video
Updated: Jan 26, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Impacting development in infants with tuberous sclerosis complex: Multidisciplinary research collaboration
Marian E Williams1, Deborah A Pearson2, Jamie K Capal3
1University of Southern California.
Insights
Researchers identified early biomarkers for autism spectrum disorder (ASD) in infants with tuberous sclerosis complex (TSC). This collaborative study also examined seizures, development, and epilepsy in young children with TSC.
Area of Science:
- Neuroscience
- Developmental Pediatrics
- Genetics
Background:
- Tuberous Sclerosis Complex (TSC) is a genetic disorder associated with increased risk of neurodevelopmental conditions, including autism spectrum disorder (ASD).
- Early identification of biomarkers for ASD in infants with TSC is crucial for timely intervention.
- Longitudinal research is needed to understand the complex interplay of neurological, developmental, and behavioral factors in TSC.
Purpose of the Study:
- To identify early biomarkers for autism spectrum disorder (ASD) in infants with tuberous sclerosis complex (TSC).
- To investigate the relationship between seizures and early development in infants and young children with TSC.
- To explore early biomarkers for epilepsy and developmental delay in this population.
Main Methods:
- A 6-site collaborative network (TACERN) conducted longitudinal research.
- Multidisciplinary teams (psychology, neurology, pediatrics, genetics, speech-language pathology) assessed neurological status, brain structure/function, and neurodevelopmental phenotype.
- Data collection focused on behavioral challenges, seizures, and developmental trajectories.
Main Results:
- Identification and measurement of early symptoms indicative of ASD in infants with TSC.
- Established correlations between seizure activity and early developmental outcomes.
- Identified potential early biomarkers for epilepsy and developmental delay in young children with TSC.
Conclusions:
- The TACERN network successfully facilitated collaborative research on TSC and ASD.
- Key insights were gained into early ASD symptoms, seizure-development relationships, and biomarkers for epilepsy/delay in TSC.
- Lessons learned from this multisite collaboration inform future research and clinical training for TSC-related neurodevelopmental disorders.
Abstract:
The Tuberous Sclerosis Complex Autism Center of Excellence Network (TACERN) is a 6-site collaborative conducting longitudinal research on infants with tuberous sclerosis complex (TSC), focused on identifying early biomarkers for autism spectrum disorder (ASD). A multidisciplinary research team that includes the specialties of psychology, neurology, pediatrics, medical genetics, and speech-language pathology, its members work together to conduct studies on neurological status, brain structure and function, neurodevelopmental phenotype, and behavioral challenges in this population. This article provides insights into the roles of the multidisciplinary multisite team and lessons learned from the collaboration, in terms of research as well as training of future researchers and clinicians. In addition, the authors detail the major findings to date, including those related to the identification and measurement of early symptoms of ASD, relationship between seizures and early development, and early biomarkers for epilepsy and developmental delay in infants and young children with TSC. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Impact of Groups on Groups
Impact
When particles with different initial velocities collide, they induce deformation by applying equal and opposite impulses. At the point of maximum deformation, the particles move together with...
Drug Dosing: Infants and Children
Sustainable Development
Impact Loading
In cases of elastic deformation,...

